Cited by 365RNA Interference and Gene DeliveryVirus-based gene therapy researchCRISPR and Genetic Engineering

Short hairpin RNA (shRNA): design, delivery, and assessment of gene knockdown

Open access
Taxman, Debra J., Moore, Chris B., Guthrie, Elizabeth H., Huang, Max Tze-Han·2010·Methods in Molecular Biology

Abstract

Shortly after the cellular mechanism of RNA interference (RNAi) was first described, scientists began using this powerful technique to study gene function. This included designing better methods for the successful delivery of small interfering RNAs (siRNAs) and short hairpin RNAs (shRNAs) into mammalian cells. While the simplest method for RNAi is the cytosolic delivery of siRNA oligonucleotides, this technique is limited to cells capable of transfection and is primarily utilized during transient in vitro studies. The introduction of shRNA into mammalian cells through infection with viral vectors allows for stable integration of shRNA and long-term knockdown of the targeted gene; however, several challenges exist with the implementation of this technology. Here we describe some well-tested protocols which should increase the chances of successful design, delivery, and assessment of gene knockdown by shRNA. We provide suggestions for designing shRNA targets and controls, a protocol for sequencing through the secondary structure of the shRNA hairpin structure, and protocols for packaging and delivery of shRNA lentiviral particles. Using real-time PCR and functional assays we demonstrate the successful knockdown of ASC, an inflammatory adaptor molecule. These studies demonstrate the practicality of including two shRNAs with different efficacies of knockdown to provide an additional level of control and to verify dose dependency of functional effects. Along with the methods described here, as new techniques and algorithms are designed in the future, shRNA is likely to include further promising application and continue to be a critical component of gene discovery.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/978-1-60761-657-3_10

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 25 · Cited by 365

Research works printed but not linked: 23

  1. [1]Fire A Xu S Montgomery MK Kostas SA Driver SE Mello CC 1998 Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans Nature 391 806 811 9486653
  2. [2]Elbashir SM Lendeckel W Tuschl T 2001 RNA interference is mediated by 21- and 22-nucleotide RNAs Genes Dev 15 188 200 11157775 PMC312613
  3. [3]Maniataki E Mourelatos Z 2005 A human, ATP-independent, RISC assembly machine fueled by pre-miRNA Genes Dev 19 2979 2990 16357216 PMC1315402
  4. [4]Kutter C Svoboda P 2008 miRNA, siRNA, piRNA: knowns of the unknown RNA Biol 5 181 188 19182524
  5. [5]Ui-Tei K Naito Y Takahashi F Haraguchi T Ohki-Hamazaki H Juni A Ueda R Saigo K 2004 Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference Nucl Acids Res 32 936 948 14769950 PMC373388
  6. [6]Taxman DJ Livingstone LR Zhang J Conti BJ Iocca HA Williams KL Lich JD Ting JP Reed W 2006 Criteria for effective design, construction, and gene knockdown by shRNA vectors BMC Biotechnol 6 7 16433925 PMC1409772
  7. [7]Reynolds A Leake D Boese Q Scaringe S Marshall WS Khvorova A 2004 Rational siRNA design for RNA interference Nat Biotechnol 22 326 330 14758366
  8. [8]Amarzguioui M Prydz H 2004 An algorithm for selection of functional siRNA sequences Biochem Biophys Res Commun 316 1050 1058 15044091
  9. [10]Mariathasan S Newton K Monack DM Vucic D French DM Lee WP Roose-Girma M Erickson S Dixit VM 2004 Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf Nature 430 213 218 15190255
  10. [11]Martinon F Burns K Tschopp J 2002 The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta Mol Cell 10 417 426 12191486
  11. [12]Huang MT Taxman DJ Holley-Guthrie EA Moore CB Willingham SB Madden V Parsons RK Feather-stone GL Arnold RR O’Connor BP 2009 Critical role of apoptotic speck protein containing a caspase recruitment domain (ASC) and NLRP3 in causing necrosis and ASC speck formation induced by Porphyromonas gingivalis in human cells J Immunol 182 2395 2404 19201894
  12. [13]Taxman DJ Zhang J Champagne C Bergstralh DT Iocca HA Lich JD Ting JP 2006 Cutting edge: ASC mediates the induction of multiple cytokines by Porphyromonas gingivalis via caspase-1-dependent and -independent pathways J Immunol 177 4252 4256 16982856
  13. [14]An DS Donahue RE Kamata M Poon B Metzger M Mao SH Bonifacino A Krouse AE Darlix JL Baltimore D 2007 Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates Proc Natl Acad Sci USA 104 13110 13115 17670939 PMC1941789
  14. [15]Brummelkamp TR Bernards R Agami R 2002 A system for stable expression of short interfering RNAs in mammalian cells Science 296 550 553 11910072
  15. [16]Schwarz DS Hutvagner G Du T Xu Z Aronin N Zamore PD 2003 Asymmetry in the assembly of the RNAi enzyme complex Cell 115 199 208 14567917
  16. [17]Xia H Mao Q Paulson HL David-son BL 2002 siRNA-mediated gene silencing in vitro and in vivo Nat Biotechnol 20 1006 1010 12244328
  17. [18]Denti MA Rosa A Sthandier O De Angelis FG Bozzoni I 2004 A new vector, based on the PolII promoter of the U1 snRNA gene, for the expression of siRNAs in mammalian cells Mol Ther 10 191 199 15272480
  18. [19]Gupta S Schoer RA Egan JE Han-non GJ Mittal V 2004 Inducible, reversible, and stable RNA interference in mammalian cells Proc Natl Acad Sci USA 101 1927 1932 14762164 PMC357029
  19. [20]Unwalla HJ Li MJ Kim JD Li HT Ehsani A Alluin J Rossi JJ 2004 Negative feedback inhibition of HIV-1 by TAT-inducible expression of siRNA Nat Biotechnol 22 1573 1578 15568018
  20. [21]Lewis J Melrose H Bumcrot D Hope A Zehr C Lincoln S Braithwaite A He Z Ogholikhan S Hinkle K 2008 In vivo silencing of alpha-synuclein using naked siRNA Mol Neurodegener 3 19 18976489 PMC2612658
  21. [22]Vlachaki MT Hernandez-Garcia A Ittmann M Chhikara M Aguilar LK Zhu X Teh BS Butler EB Woo S Thompson TC 2002 Impact of preimmunization on adenoviral vector expression and toxicity in a subcutaneous mouse cancer model Mol Ther 6 342 348 12231170
  22. [23]Monahan PE Jooss K Sands MS 2002 Safety of adeno-associated virus gene therapy vectors: a current evaluation Expert Opin Drug Saf 1 79 91 12904163
  23. [24]Bot I Guo J Van Eck M Van Santbrink PJ Groot PH Hildebrand RB Seppen J Van Berkel TJ Biessen EA 2005 Lentiviral shRNA silencing of murine bone marrow cell CCR2 leads to persistent knockdown of CCR2 function in vivo Blood 106 1147 1153 15886324

Authors
Taxman, D. J., Moore, C. B., Guthrie, E. H., & Huang, M. T.-H.
Affiliations
University of North Carolina at Chapel Hill (US)
Venue
Methods in Molecular Biology
Publisher
Humana Press
Published
2010
Volume
629
Pages
139-156
ISSN
  • 1064-3745 (ISSN-L)
  • 1940-6029
OpenAlex
W1924139413
Cited by
365
References
25
Citations by year
2026: 10 · 2025: 23 · 2024: 43 · 2023: 44 · 2022: 40 · 2021: 35 · 2020: 33 · 2019: 32 · 2018: 17 · 2017: 17 · 2016: 30 · 2015: 15 · 2014: 15 · 2013: 4 · 2012: 1
FWCI
4.27
Type
book chapter
Language
en
Open access
Locations
  • Methods in molecular biology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (5r01de016326-05)
  • National Institute of Allergy and Infectious Diseases (U54AI057157)
  • National Institute of Dental and Craniofacial Research (R01-DE016326, 1-RO1-DE016326)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
Keywords
shRNA, RNA interference, gene knockdown, shRNA design, shRNA delivery, lentiviral vectors, siRNA delivery, hairpin secondary structure, ASC, dose dependency
MeSH terms
Cell Adhesion, Cell Line, Enzyme-Linked Immunosorbent Assay, Humans, Transduction, Genetic, Reproducibility of Results, Lentivirus, Sequence Analysis, RNA, Virus Assembly, Reverse Transcriptase Polymerase Chain Reaction, RNA, Small Interfering, Adaptor Proteins, Signal Transducing, Interleukin-1beta, Gene Knockdown Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review